GlucoTrack, Inc.
Key Metrics
- Previous Close
- $1.41
- 52-Week Range
- $1.15 – $136.29
- Market Cap
- $1.23M
- P/E (TTM)
- —
- EPS (TTM)
- -123.15
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- -620.63%
- Return on Assets
- -164.45%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 0.46
- Debt/Equity
- —
- Total Debt
- $1.96M
- Free Cash Flow
- $-10.39M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $1.69M
Market Snapshot
About
GlucoTrack, Inc. is a medical device company focused on developing and commercializing non-invasive glucose monitoring technology for diabetes management. The company's proprietary technology uses ultrasonic, electromagnetic, and thermal sensors to measure glucose levels without requiring finger-prick blood samples. GlucoTrack's device is designed to provide diabetic patients with a pain-free alternative to traditional blood glucose monitoring methods. The company has received regulatory clearances in certain markets and is working to expand commercialization and pursue additional regulatory approvals. GlucoTrack aims to improve quality of life for diabetes patients by eliminating the discomfort and inconvenience associated with conventional glucose testing methods.